AdvaMed Encourages Risk-Based FDA Approach to Generative AI Medical Devices - AdvaMed®

A risk-based regulatory approach could help tailor oversight to the potential harms of different generative AI medical devices. The debate matters because regulatory choices can affect both patient safeguards and the path to bringing these technologies into use.